CTOs on the Move

OurLab - Oppenheimer Urologic Reference Laborato

www.ourlab.net

 
OurLab - Oppenheimer Urologic Reference Laboratory is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.ourlab.net
  • 1450 Elm Hill Pike
    Nashville, TN USA 37210
  • Phone: 615.874.0410

Executives

Name Title Contact Details

Similar Companies

San Diego Reference Laboratory

San Diego Reference Laboratory is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Midtown Imaging

Midtown's Jupiter Women's Imaging Center is designed to meet the unique health care needs of women in one convenient, community-based location. Midtown's goal is to provide outstanding diagnostic imaging services, emotional comfort and time efficiency

Medical Imaging Of Teaneck

Medical Imaging Of Teaneck is a Teaneck, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Columbia Analytical Services Inc

Columbia Analytical Services Inc is a Kelso, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Gritstone Oncology

Gritstone Oncology is a privately-held company headquartered in the San Francisco Bay Area with key functions located in Cambridge, Massachusetts and Pleasanton, California. We launched in October 2015, and since inception, have successfully raised two large, private financing rounds. We currently employ more than 60 professionals. We have brought together a group of distinguished scientific founders and advisors, a highly experienced and diverse leadership team and a seasoned and successful board of directors to tackle fundamental challenges at the intersection of cancer genomics and immunotherapy. With our unique approach to immuno-oncology, we are developing next-generation personalized immunotherapies to fight cancer in patients with the most difficult-to-treat tumors. We plan to combine these personalized neoantigen-targeted therapies with current immune checkpoint modulatory approaches to improve response rates and survival in patients with solid tumors.